Evidence map›Paper›PMID 40169480›Full record

ArticleAnnals of surgical oncology2025

ASO Author Reflections: Serum Enzymes as Predictive Biomarkers for Pathologic Complete Response in HER2-Positive Breast Cancer.

Zongshun Chen, Jing Zhang, Wei Chen, Xueyi Chen, Da-Lin Lu, Junjie Li

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zongshun Chen *School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Jing Zhang *Department of Epidemiology, School of Medicine, Jinan University, Guangdong, Tianhe District, Guangdong, China.
Wei ChenSchool of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Xueyi ChenDepartment of Breast Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Da-Lin Lu *Department of Epidemiology, School of Medicine, Jinan University, Guangdong, Tianhe District, Guangdong, China. ludalin999@163.com.ORCID http://orcid.org/0000-0002-6896-6835
Junjie Li *Department of Breast Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. lijunjie@scszlyy.org.cn.ORCID http://orcid.org/0000-0003-4510-8261

Funding

China Primary Health Care Foundation cphcf-2023-158National Natural Science Foundation of China 82003522Natural Science Foundation of Sichuan Province 2023NSFSC0548Wu Jieping Medical Foundation 320.6750.2023-18-99
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40169480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.